Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cell Cycle, Cell Death, and Senescence

Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand

Takashi Yasuda, Tatsushi Yoshida, Ahmed E. Goda, Mano Horinaka, Kimihiro Yano, Takumi Shiraishi, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki and Toshiyuki Sakai
Takashi Yasuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsushi Yoshida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed E. Goda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mano Horinaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimihiro Yano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takumi Shiraishi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miki Wakada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoichi Mizutani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuneharu Miki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiyuki Sakai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1541-7786.MCR-08-0012 Published December 2008
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: December 2008 to January 2021

AbstractFull-text HTMLPDF
Total257230871458

Cited By

Article Information

Volume 6, Issue 12, pp. 1852-1860

DOI 
https://doi.org/10.1158/1541-7786.MCR-08-0012
PubMed 
19074830

Published By 
American Association for Cancer Research
Print ISSN 
1541-7786
Online ISSN 
1557-3125
History 
  • September 4, 2008
  • January 8, 2008
  • August 6, 2008
  • Published first December 15, 2008.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Takashi Yasuda12,
  2. Tatsushi Yoshida1,
  3. Ahmed E. Goda13,
  4. Mano Horinaka1,
  5. Kimihiro Yano12,
  6. Takumi Shiraishi2,
  7. Miki Wakada1,
  8. Yoichi Mizutani2,
  9. Tsuneharu Miki2 and
  10. Toshiyuki Sakai1
  1. Departments of 1Molecular-Targeting Cancer Prevention and 2Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan and 3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt
  1. Toshiyuki Sakai, Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. Phone: 81-75-251-5339; Fax: 81-75-241-0792. E-mail: tsakai{at}koto.kpu-m.ac.jp
View Full Text
PreviousNext
Back to top
Molecular Cancer Research: 6 (12)
December 2008
Volume 6, Issue 12
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
Takashi Yasuda, Tatsushi Yoshida, Ahmed E. Goda, Mano Horinaka, Kimihiro Yano, Takumi Shiraishi, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki and Toshiyuki Sakai
Mol Cancer Res December 1 2008 (6) (12) 1852-1860; DOI: 10.1158/1541-7786.MCR-08-0012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
Takashi Yasuda, Tatsushi Yoshida, Ahmed E. Goda, Mano Horinaka, Kimihiro Yano, Takumi Shiraishi, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki and Toshiyuki Sakai
Mol Cancer Res December 1 2008 (6) (12) 1852-1860; DOI: 10.1158/1541-7786.MCR-08-0012
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Disclosure of Potential Conflicts of Interest
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Role of Bcl-xL in a Multimodality Treatment
  • CDC25 Opposes ATM Activity during Development
  • Estrogen Receptor and Bortezomib Action
Show more Cell Cycle, Cell Death, and Senescence
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement